175 related articles for article (PubMed ID: 28835680)
1. Transcriptome analysis of ankylosing spondylitis patients before and after TNF-α inhibitor therapy reveals the pathways affected.
Wang XB; Ellis JJ; Pennisi DJ; Song X; Batra J; Hollis K; Bradbury LA; Li Z; Kenna TJ; Brown MA
Genes Immun; 2017 Sep; 18(3):184-190. PubMed ID: 28835680
[TBL] [Abstract][Full Text] [Related]
2. Relation of HLA-B27, tumor necrosis factor-α promoter gene polymorphisms, and T cell cytokine production in ankylosing spondylitis -- a comprehensive genotype-phenotype analysis from an observational cohort.
Poddubnyy DA; Märker-Hermann E; Kaluza-Schilling W; Zeidler H; Braun J; Listing J; Sieper J; Rudwaleit M
J Rheumatol; 2011 Nov; 38(11):2436-41. PubMed ID: 21885496
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-α promoter -308/238 polymorphism association with less severe disease in ankylosing spondylitis is unrelated to serum TNF-α and does not predict TNF inhibitor response.
Nossent JC; Sagen-Johnsen S; Bakland G
J Rheumatol; 2014 Aug; 41(8):1675-82. PubMed ID: 25028373
[TBL] [Abstract][Full Text] [Related]
4. Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5.
Assassi S; Reveille JD; Arnett FC; Weisman MH; Ward MM; Agarwal SK; Gourh P; Bhula J; Sharif R; Sampat K; Mayes MD; Tan FK
J Rheumatol; 2011 Jan; 38(1):87-98. PubMed ID: 20952467
[TBL] [Abstract][Full Text] [Related]
5. The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis.
Chatzikyriakidou A; Georgiou I; Voulgari PV; Drosos AA
Clin Exp Rheumatol; 2009; 27(4):645-8. PubMed ID: 19772798
[TBL] [Abstract][Full Text] [Related]
6. Dosage adjustment of anti-tumor necrosis factor-α inhibitor in ankylosing spondylitis is effective in maintaining remission in clinical practice.
Paccou J; Baclé-Boutry MA; Solau-Gervais E; Bele-Philippe P; Flipo RM
J Rheumatol; 2012 Jul; 39(7):1418-23. PubMed ID: 22707611
[TBL] [Abstract][Full Text] [Related]
7. Targeting tumor necrosis factor receptors in ankylosing spondylitis.
Lata M; Hettinghouse AS; Liu CJ
Ann N Y Acad Sci; 2019 Apr; 1442(1):5-16. PubMed ID: 30008173
[TBL] [Abstract][Full Text] [Related]
8. Working life and physical activity in ankylosing spondylitis pre and post anti-tumor necrosis factor-alpha therapy.
Prince DS; McGuigan LE; McGirr EE
Int J Rheum Dis; 2014 Feb; 17(2):165-72. PubMed ID: 24576272
[TBL] [Abstract][Full Text] [Related]
9. Effects of tumor necrosis factor inhibitor on serum level of HLA-B27 and PDCD-1 in patients with ankylosing spondylitis.
Chen X; Zhou X; Li X; Tang J; Hu X; Wang J; Xu C
Cell Biochem Biophys; 2014 Nov; 70(2):1453-7. PubMed ID: 25005770
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha blockade leads to decreased peripheral T cell reactivity and increased dendritic cell number in peripheral blood of patients with ankylosing spondylitis.
Pang L; Wang L; Suo T; Hao H; Fang X; Jia J; Huang F; Tang J
J Rheumatol; 2008 Nov; 35(11):2220-8. PubMed ID: 19004053
[TBL] [Abstract][Full Text] [Related]
11. Drug insight: anti-tumor-necrosis-factor therapy for ankylosing spondylitis.
Henderson C; Davis JC
Nat Clin Pract Rheumatol; 2006 Apr; 2(4):211-8. PubMed ID: 16932687
[TBL] [Abstract][Full Text] [Related]
12. Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years.
Poddubnyy D; Fedorova A; Listing J; Haibel H; Baraliakos X; Braun J; Sieper J
J Rheumatol; 2016 Dec; 43(12):2142-2148. PubMed ID: 27803139
[TBL] [Abstract][Full Text] [Related]
13. Is secukinumab a safe alternative treatment for ankylosing spondylitis with Guillain Barré syndrome after anti-TNF-α treatment? Case report and literature review.
Psarelis S; Hajineocli APD; Hadjicosta E; Elliott HSA; Johnson P
Clin Rheumatol; 2017 May; 36(5):1197-1199. PubMed ID: 28233109
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
[TBL] [Abstract][Full Text] [Related]
15. Identification of potential transcriptomic markers in developing ankylosing spondylitis: a meta-analysis of gene expression profiles.
Fang F; Pan J; Xu L; Li G; Wang J
Biomed Res Int; 2015; 2015():826316. PubMed ID: 25688367
[TBL] [Abstract][Full Text] [Related]
16. Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis.
Caso F; Costa L; Del Puente A; Rigante D; Selmi C; Fabbroni M; Scarpa R; Galeazzi M; Frediani B; Cantarini L
Clin Exp Rheumatol; 2015; 33(3):411-3. PubMed ID: 25962691
[TBL] [Abstract][Full Text] [Related]
17. The effect of anti-TNF treatment on osteoblastogenesis in ankylosing spondylitis: the number of circulating osteoblast-lineage cells in peripheral blood decreased after infliximab therapy in patients with ankylosing spondylitis.
Kwon SR; Jung KH; Lim MJ; Son MJ; Choi BH; Park SG; Park W
Clin Exp Rheumatol; 2017; 35(5):837-843. PubMed ID: 28375831
[TBL] [Abstract][Full Text] [Related]
18. Plasma, urine and ligament tissue metabolite profiling reveals potential biomarkers of ankylosing spondylitis using NMR-based metabolic profiles.
Wang W; Yang GJ; Zhang J; Chen C; Jia ZY; Li J; Xu WD
Arthritis Res Ther; 2016 Oct; 18(1):244. PubMed ID: 27770826
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome-Wide Association Studies and Integration Analysis of mRNA Expression Profiles Identify Candidate Genes and Pathways Associated With Ankylosing Spondylitis.
Feng R; Lu M; Liu L; Xu K; Xu P
Front Immunol; 2022; 13():814303. PubMed ID: 35619696
[TBL] [Abstract][Full Text] [Related]
20. Predictors of Switching Anti-Tumor Necrosis Factor Therapy in Patients with Ankylosing Spondylitis.
Lee JW; Kang JH; Yim YR; Kim JE; Wen L; Lee KE; Park DJ; Kim TJ; Park YW; Lee SS
PLoS One; 2015; 10(7):e0131864. PubMed ID: 26176701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
